Atara Biotherapeutics Cash Flow Statement (2021-2026) | ATRA

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -88.11M18.47M-84.09M-74.68M-74.77M-71.11M-69.80M-60.70M-31.75M-19.05M-21.91M-12.69M38.01M2.39M-4.30M-36.14M-4.14M
Depreciation and Depletion (Quarter) 1.50M1.40M1.10M0.90M0.90M0.90M0.90M0.90M0.90M0.70M0.60M0.50M0.30M0.10M
Share-based Compensation (Quarter) 14.34M14.12M14.02M11.36M11.76M12.55M11.14M9.93M8.40M6.34M6.42M5.85M4.21M2.80M1.23M1.52M0.75M
Gains from Sales and Divestitures (Quarter) 1.55M0.45M1.10M1.61M2.25M0.48M1.55M2.38M3.69M1.57M0.14M0.22M0.32M0.07M0.28M0.39M0.45M0.06M
Gains from Investment Securities (Quarter) 2.64M0.62M0.79M5.60M50.22M0.96M1.93M1.87M0.41M0.12M0.12M0.87M0.25M0.39M0.39M-0.06M200.00
Asset Writedowns and Impairment (Quarter) 4.13M
Non-cash Items (Quarter) 12.81M0.33M0.95M0.09M0.04M35.70M31.40M23.40M29.90M23.80M7.00M0.03M8.60M0.40M0.01M0.02M
Cash from Operations (Quarter) -84.53M-63.96M-65.06M-56.88M-38.43M-52.80M-51.35M-50.41M-29.61M-10.64M-3.99M-24.47M-28.14M-7.32M-9.79M-5.70M-3.07M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) -0.50M-0.31M-0.16M-0.05M1.20M1.25M1.27M1.06M1.05M-1.07M0.06M4.08M-0.26M2.07M-1.98M-0.08M0.81M
Depreciation & Amortization (CF) (Quarter) 1.59M1.40M1.40M1.25M1.21M1.20M1.21M1.21M1.39M1.33M1.23M1.10M1.79M0.24M0.04M0.05M0.03M
Change in Working Capital
Change in Receivables (Quarter) -0.32M-0.03M-0.39M39.97M-39.82M0.11M-0.34M33.95M1.73M-33.41M-1.09M0.15M7.39M-8.88M1.91M-0.66M-1.25M
Change in Inventory (Quarter) 1.59M3.75M2.52M-1.27M3.12M6.38M2.67M-4.77M0.16M-10.65M
Change in Account Payables (Quarter) -4.59M1.20M-1.38M-4.45M-1.89M-0.89M2.46M-2.81M-0.83M2.40M-3.11M2.22M-2.98M-0.08M-0.98M-0.19M0.51M
Change in Accured Expenses (Quarter) -8.77M-0.06M14.43M-3.53M-0.61M-4.49M5.71M-6.75M-5.81M1.56M-6.20M-2.06M-1.99M0.55M-3.08M-0.80M-0.17M
Other Working Capital Changes (Quarter) -0.65M0.79M-6.92M-1.23M2.96M-9.99M7.56M-13.18M-0.44M-6.80M-0.82M7.60M-0.01M0.01M-0.28M
Investing Activities
Capital Expenditures (Quarter) 1.19M-1.06M-0.10M0.03M0.40M-0.29M-0.09M0.11M0.13M0.03M0.09M
Sales of Property, Plant and Equipment (Quarter) 0.04M0.56M
Change in Acquisitions & Divestments (Quarter) 89.25M77.14M75.90M50.68M62.30M65.72M70.70M9.99M14.84M7.22M3.00M3.47M17.20M0.00M7.88M
Cash from Investing Activities (Quarter) 60.22M31.83M59.70M51.22M-6.01M49.48M70.45M9.94M14.72M7.20M-16.66M3.38M17.20M-5.07M-2.42M8.44M
Financing Activities
Other financing activities (Quarter) -0.10M-0.05M30.76M-0.01M
Cash from Financing Activities (Quarter) 19.85M1.16M-0.21M32.29M0.23M0.47M-0.21M1.51M24.14M-0.32M35.79M-0.33M-0.25M15.30M1.05M-0.00M2.95M
Additional items
Change in Cash (Quarter) -4.46M-30.98M-5.57M26.63M-44.20M-2.84M18.89M-38.95M9.25M-3.77M15.14M-21.42M-11.19M2.92M-11.16M2.74M-0.12M
Free Cash Flow (Quarter) -85.72M-62.91M-64.96M-56.91M-38.83M-52.51M-51.26M-50.52M-29.74M-10.67M-3.99M-24.56M-28.14M-7.32M-9.79M-5.70M-3.07M
Net Cash Flow (Quarter) -4.46M-30.98M-5.57M26.63M-44.20M-2.84M18.89M-38.95M9.25M-3.77M15.14M-21.42M-11.19M2.92M-11.16M2.74M-0.12M